VYNE
Vyne Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$21.28M
P/E Ratio
—
EPS
$-0.63
Beta
1.95
52W High
$1.96
52W Low
$0.28
50-Day MA
$0.61
200-Day MA
$0.52
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vyne Therapeutics Inc
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapies for dermatology. The company is headquartered in Bridgewater, New Jersey.
Fundamentals
| Revenue (TTM) | 570,000 |
| Gross Profit (TTM) | 570,000 |
| EBITDA | $-29.73M |
| Operating Margin | -4015.00% |
| Return on Equity | -67.00% |
| Return on Assets | -38.30% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.83 |
| Price-to-Book | 0.77 |
| Price-to-Sales (TTM) | 37.33 |
| EV/Revenue | 10.04 |
| EV/EBITDA | 1.84 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 54.80% |
| Shares Outstanding | $33.32M |
| Float | $32.53M |
| % Insiders | 4.34% |
| % Institutions | 26.83% |
Historical Volatility
HV 10-Day
24.01%
HV 20-Day
23.35%
HV 30-Day
35.91%
HV 60-Day
31.73%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/28/2026